Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome

NCT06053983 is registered in ClinicalTrials.gov with Rawalpindi Medical College as lead sponsor.

NCT NCT06053983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06053983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome
Lead sponsor
Rawalpindi Medical College
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2023
Completion date
August 1, 2023
Enrollment
126 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mi q wave